CORRELATION OF DASHAVIDHA PARIKSHA WITH SPECIFIC PRO-INFLAMMATORY CYTOKINE PROFILES IN PATIENTS WITH RHEUMATOID ARTHRITIS (AMAVATA )
Main Article Content
Keywords
Ayurveda, Amavata , Rheumatoid Arthritis, Dashavidha Pariksha, TNF-α, IL-6, Neuro-immunology, Personalized Medicine.
Abstract
Rheumatoid Arthritis (RA), clinically correlated with Amavata is a chronic autoimmune syndrome characterized by persistent synovial inflammation and systemic immune dysregulation. While modern rheumatology utilizes objective biomarkers, Ayurveda employs the Dashavidha Pariksha (Tenfold Examination) for comprehensive patient phenotyping. This study analyzes the correlation between the ten parameters Prakriti, Vikriti, Sara, Samhanana, Pramana, Satmya, Satva, Ahara Shakti, Vyayama Shakti, and Vaya and the systemic titers of pro-inflammatory cytokines, specifically Tumor Necrosis Factor-alpha (TNF-α), Interleukin-6 (IL-6), and Interleukin-1 (IL-1).[i] Evidence suggests that Vata -predominant Prakriti and high-degree Vikriti scores are associated with elevated TNF-α and IL-6 levels. Furthermore, parameters like Satva and Ahara Shakti demonstrate significant correlations with the neuro-endocrine-immune axis and gut-microbiota-driven inflammation. Integrating these ancient diagnostic metrics provides a robust framework for personalized medicine and patient-centric prognosis in autoimmune pathology.
References
Agnivesha. (2020). Charaka Samhita, Vimana Sthana Chapter 8 (Rogabhishagjitiya Vimana), Shloka 94-122. (Y. S. Deole, Ed.). Charak Samhita Research, Training and Skill Development Centre. DOI: 10.47468/CSNE.2020.e01.s03.009.
Sushruta. (2017). Sushruta Samhita, Doshadhatumala Kshaya Vriddhi Vijnaniya (Sutra Sthana 15/40). (Dr. Anant Ram Sharma, Ed.). Chaukhambha Sanskrita Sansthan.
Yogaratnakara. (2005). Yogaratnakara, Amavata Chikitsa (Poorva Khanda). (Dr. Madhavam Shetty Sureshbabu, Ed.). Chaukhamba Sanskrit Series. Page 132.
Yogita, et al. (2025). Dashavidha Pareeksha: A comprehensive clinical assessment model in Ayurveda. World Journal of Pharmacy and Pharmaceutical Sciences, 14(7), 231-240.
Vagbhata. (2025). Ashtanga Hridaya, Roganutpadaniya (Sutrasthana 12/67). (Dr. Brahmanand Tripathi, Ed.). Chaukhambha Publications.
Singh, A., et al. (2019). Need of development of diagnostic measures for assessment of Sara Pariksha in Ayurveda. International Journal of Health Sciences & Research, 9(7), 272-278.
Agnivesha. (2020). Charaka Samhita, Trividhakukshiya Vimana (Vimana Sthana 2/3). (Y. S. Deole, Ed.). Charak Samhita Research, Training and Skill Development Centre.
Lee, J. H., et al. (2021). Circulating cytokines and rheumatoid arthritis: A systematic review and meta-analysis. Scientific Reports, 11, 23. DOI: 10.1038/s41598-021-0131.
Madhava. (2023). Madhava Nidana, Chapter 25 (AmaVata Nidanam), Shloka 6. (Dr. Brahmanand Tripathi, Trans.). Chaukhambha Surbharati Prakashan.
Rastogi, S., et al. (2024). Clinical metabolomics investigation of rheumatoid arthritis: Identifying the serum metabolic signatures following Ayurvedic Whole System (AWS) intervention. Journal of Ayurveda and Integrative Medicine. DOI: 10.1016/j.jaim.2024.101009.
Arden, J., et al. (1967). Immunoglobulin levels in rheumatoid arthritis: comparison with rheumatoid factor titers, clinical stage and disease duration. Arthritis Rheum, 10(3), 228-234. DOI: 10.1002/art.1780100308.
Kumar, S., et al. (2024). A comparative study to assess the treatment cost of Ayurvedic medicine (ginger and castor oil) and modern medicine (DMARDs) in AmaVata (Rheumatoid Arthritis). International Journal of Ayurveda and Pharma Research, 12(6), 111-118.
Furst, D. E., et al. (2011). Double-blind, randomized, controlled, pilot study comparing classic Ayurvedic medicine, methotrexate, and their combination in rheumatoid arthritis. Journal of Clinical Rheumatology, 17(4), 185-192. DOI: 10.1097/RHU.0b013e31821c03d0.
Arden, J., et al. (1967). Immunoglobulin levels in rheumatoid arthritis: comparison with rheumatoid factor titers, clinical stage and disease duration. Arthritis Rheum, 10(3), 228-234. DOI: 10.1002/art.1780100308.

